Cargando…

Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort

OBJECTIVES: Neurological manifestations seem common in primary Sjögren's syndrome (pSS) but their reported prevalences vary. We investigated the prevalence and epidemiology of neurological manifestations in a French nationwide multicentre prospective cohort of patients with pSS, the Assessment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carvajal Alegria, Guillermo, Guellec, Dewi, Mariette, Xavier, Gottenberg, Jacques-Eric, Dernis, Emmanuelle, Dubost, Jean-Jacques, Trouvin, Anne-Priscille, Hachulla, Eric, Larroche, Claire, Le Guern, Veronique, Cornec, Divi, Devauchelle-Pensec, Valérie, Saraux, Alain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Connective Tissue Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838763/ https://www.ncbi.nlm.nih.gov/pubmed/27110384 http://dx.doi.org/10.1136/rmdopen-2015-000179

Ejemplares similares

EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide
por: Seror, Raphaèle, et al.
Publicado: (2015)

Impact of patient ancestry on heterogeneity of Sjögren’s disease
por: Beydon, Maxime, et al.
Publicado: (2023)

ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome?
por: Payet, J, et al.
Publicado: (2015)

Seasonal effect on fatigue, pain and dryness in primary Sjögren’s syndrome
por: Duret, Pierre-Marie, et al.
Publicado: (2020)

Salivary Glands and Periodontal Changes in a Population of Sjögren's and Sicca Syndrome Treated by Pilocarpine: A Pilot Study
por: Depinoy, Thibaud, et al.
Publicado: (2020)

Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren’s Syndrome?
por: Devauchelle-Pensec, Valérie, et al.
Publicado: (2015)

Dermatomyositis flare on imiquimod therapy highlights a crucial role of aberrant TLR7 signalling
por: Meyer, Alain, et al.
Publicado: (2016)

Comparison between primary Sjögren’s disease patients with high or low level of dryness
por: Kachaner, Alexandra, et al.
Publicado: (2023)

Inflammatory Markers are Quickly Improved by Tocilizumab in Early Polymyalgia Rheumatica and Might Predict Early Response to Interleukin-6 Blockade
por: Carvajal Alegria, Guillermo, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on therapeutic management of rheumatoid arthritis in Brittany (France)
por: Queré, Baptiste, et al.
Publicado: (2021)

Impact de la pandémie à COVID-19 sur la prise en charge thérapeutique des patients présentant une polyarthrite rhumatoïde en Bretagne (France)()
por: Queré, Baptiste, et al.
Publicado: (2022)

Serum Levels of Beta2-Microglobulin and Free Light Chains of Immunoglobulins Are Associated with Systemic Disease Activity in Primary Sjögren’s Syndrome. Data at Enrollment in the Prospective ASSESS Cohort
por: Gottenberg, Jacques-Eric, et al.
Publicado: (2013)

Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohort
por: Truchetet, Marie-Elise, et al.
Publicado: (2022)

Level of agreement between 2002 American–European Consensus Group and 2012 American College of Rheumatology classification criteria for Sjögren’s syndrome and reasons for discrepancies
por: Cornec, Divi, et al.
Publicado: (2014)

Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines
por: Howard Tripp, Nadia, et al.
Publicado: (2016)

Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients
por: Danion, François, et al.
Publicado: (2017)

Ultrasonography and magnetic resonance imaging changes in patients with polymyalgia rheumatica treated by tocilizumab
por: Huwart, Anaïs, et al.
Publicado: (2018)

Diagnostic accuracy of blood B-cell subset profiling and autoimmunity markers in Sjögren’s syndrome
por: Cornec, Divi, et al.
Publicado: (2014)

Comparison of 2002 AECG and 2016 ACR/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjögren’s syndrome
por: Le Goff, Maëlle, et al.
Publicado: (2017)

Preconception clinical factors related to adverse pregnancy outcomes in patients with systemic lupus erythematosus or primary Sjögren’s syndrome: a retrospective cohort study
por: Fierro, Juan J., et al.
Publicado: (2023)

Development and preliminary validation of the Sjögren’s Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren’s syndrome
por: Seror, Raphaele, et al.
Publicado: (2022)

B-cell and T-cell quantification in minor salivary glands in primary Sjögren’s syndrome: development and validation of a pixel-based digital procedure
por: Costa, Sebastian, et al.
Publicado: (2016)

Eosinophilia predicts poor clinical outcomes in recent-onset arthritis: results from the ESPOIR cohort
por: Guellec, Dewi, et al.
Publicado: (2015)

Diagnostic impact of routine Lyme serology in recent-onset arthritis: results from the ESPOIR cohort
por: Guellec, Dewi, et al.
Publicado: (2016)

High-Grade Salivary-Gland Involvement, Assessed by Histology or Ultrasonography, Is Associated with a Poor Response to a Single Rituximab Course in Primary Sjögren’s Syndrome: Data from the TEARS Randomized Trial
por: Cornec, Divi, et al.
Publicado: (2016)

Clinical practice guidelines adherence, knowledge and awareness in rare and complex connective tissue diseases across Europe: results from the first ERN ReCONNET survey
por: Talarico, Rosaria, et al.
Publicado: (2020)

IgG4-related diseases: state of the art on clinical practice guidelines
por: Iaccarino, Luca, et al.
Publicado: (2019)

Mixed connective tissue disease: state of the art on clinical practice guidelines
por: Chaigne, Benjamin, et al.
Publicado: (2018)

Obstetrical outcome and treatments in seronegative primary APS: data from European retrospective study
por: Abisror, Noemie, et al.
Publicado: (2020)

Undifferentiated connective tissue disease: state of the art on clinical practice guidelines
por: Antunes, Margarida, et al.
Publicado: (2019)

Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines
por: Meyer, Alain, et al.
Publicado: (2019)

Peripheral-blood b-cell subset disturbances in inflammatory joint diseases induced by Tropheryma whipplei
por: Le Goff, Maëlle, et al.
Publicado: (2019)

Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
por: Yeoh, Su-Ann, et al.
Publicado: (2022)

Anti-SMN autoantibodies in mixed connective tissue disease are associated with a severe systemic sclerosis phenotype
por: El Kamouni, Hajar, et al.
Publicado: (2023)

A prediction model for progressive disease in systemic sclerosis
por: Meijs, Jessica, et al.
Publicado: (2015)

EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report
por: Bottai, Matteo, et al.
Publicado: (2017)

Increased B-cell activating factor (BAFF)/B-lymphocyte stimulator (BLyS) in primary antiphospholipid syndrome is associated with higher adjusted global antiphospholipid syndrome scores
por: van den Hoogen, Lucas L, et al.
Publicado: (2018)

Prevalence and clinical correlates of rheumatoid factor and anticitrullinated protein antibodies in patients with idiopathic inflammatory myopathy
por: Ide, Veerle, et al.
Publicado: (2018)

Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses
por: Chen, Bo, et al.
Publicado: (2019)

Distinct interferon signatures stratify inflammatory and dysimmune myopathies
por: Rigolet, Muriel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m1gs0s65tnbv880akvogq6u6f9